Daiwa Securities Group Inc.
Broker-DealerPosition in RPRX — Royalty Pharma plc
CIK 1481045
CHIYODA-KU,TOKYO, M0
Position in RPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,006,441
+$603,887 QoQ
Shares Held
41,827
+15.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Daiwa Securities Group Inc. holds $105,367,050 across 28 Biotechnology names. RPRX ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
67,539 | $30,158,865 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,525 | $28,220,675 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,364 | $8,392,185 | |
| 4 | TECH |
BIO-TECHNE Corp
|
145,000 | $7,577,699 | |
| 5 | INSM |
INSMED Inc
|
39,429 | $6,447,430 | |
| 6 | INCY |
Incyte Corp
|
39,366 | $3,705,127 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
15,000 | $2,835,750 | |
| 8 | RPRX |
Royalty Pharma plc
This page
|
41,827 | $2,006,441 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,006,441 | 41,827 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,402,554 | 36,298 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,167,344 | 33,088 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,149,212 | 31,896 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $991,365 | 31,846 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $777,952 | 30,496 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $868,333 | 30,694 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $730,290 | 27,694 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $805,230 | 26,514 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,029,301 | 36,643 | Shares | Other | 2024-01-31 | |
| 2023-09-30 | $885,741 | 32,636 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,013,989 | 32,986 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,131,269 | 31,398 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,226,187 | 31,027 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,171,970 | 29,168 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,219,412 | 29,006 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,082,893 | 27,795 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $726,425 | 18,229 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $644,376 | 17,830 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $679,614 | 16,580 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $678,770 | 15,561 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $855,854 | 17,100 | Shares | Other | 2021-02-04 | |
| 2020-09-30 | $598,824 | 14,234 | Shares | Other | 2020-11-02 | |
| No filing history on record for this holder in this stock. | ||||||